THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
In the article the authors consider some concerns of clinical efficacy and safety of rosuvastatin - the most powerful representative of the group of statins. The review contains the results of clinical trials, demonstrating its high lipid-lowering efficacy, impact on surrogate and primary endpoints...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2013-06-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/5550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849692958130962432 |
|---|---|
| author | V. V. Kukharchuk P. P. Malyshev |
| author_facet | V. V. Kukharchuk P. P. Malyshev |
| author_sort | V. V. Kukharchuk |
| collection | DOAJ |
| description | In the article the authors consider some concerns of clinical efficacy and safety of rosuvastatin - the most powerful representative of the group of statins. The review contains the results of clinical trials, demonstrating its high lipid-lowering efficacy, impact on surrogate and primary endpoints in studies on primary and secondary prevention. They also discuss safety treatment concerns with this drug, and its possible side effects. The authors present data on the comparative efficacy and tolerability of generic form of rosuvastatin (Mertenil, Gedeon Richter) which had been received by Russian and foreign researchers, the evidence about the comparability of therapeutic efficacy and safety of the generic to the original form. |
| format | Article |
| id | doaj-art-c9d36b8e249647f2b99cc6028157cddb |
| institution | DOAJ |
| issn | 2225-1685 2305-0748 |
| language | Russian |
| publishDate | 2013-06-01 |
| publisher | InterMedservice |
| record_format | Article |
| series | Евразийский Кардиологический Журнал |
| spelling | doaj-art-c9d36b8e249647f2b99cc6028157cddb2025-08-20T03:20:34ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482013-06-0102354210.38109/2225-1685-2013-2-35-425547THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETYV. V. Kukharchuk0P. P. Malyshev1Russian Cardiology Research ComplexRussian Cardiology Research ComplexIn the article the authors consider some concerns of clinical efficacy and safety of rosuvastatin - the most powerful representative of the group of statins. The review contains the results of clinical trials, demonstrating its high lipid-lowering efficacy, impact on surrogate and primary endpoints in studies on primary and secondary prevention. They also discuss safety treatment concerns with this drug, and its possible side effects. The authors present data on the comparative efficacy and tolerability of generic form of rosuvastatin (Mertenil, Gedeon Richter) which had been received by Russian and foreign researchers, the evidence about the comparability of therapeutic efficacy and safety of the generic to the original form.https://www.heartj.asia/jour/article/view/5550атеросклерозмертенилрозувастатинстатиныatherosclerosisrosuvastatinmertenilstatins |
| spellingShingle | V. V. Kukharchuk P. P. Malyshev THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY Евразийский Кардиологический Журнал атеросклероз мертенил розувастатин статины atherosclerosis rosuvastatin mertenil statins |
| title | THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY |
| title_full | THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY |
| title_fullStr | THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY |
| title_full_unstemmed | THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY |
| title_short | THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY |
| title_sort | concerns of rosuvastatin clinical efficacy and safety |
| topic | атеросклероз мертенил розувастатин статины atherosclerosis rosuvastatin mertenil statins |
| url | https://www.heartj.asia/jour/article/view/5550 |
| work_keys_str_mv | AT vvkukharchuk theconcernsofrosuvastatinclinicalefficacyandsafety AT ppmalyshev theconcernsofrosuvastatinclinicalefficacyandsafety AT vvkukharchuk concernsofrosuvastatinclinicalefficacyandsafety AT ppmalyshev concernsofrosuvastatinclinicalefficacyandsafety |